Results 101 to 110 of about 210,178 (301)

Disseminated cryptococcosis in an HIV patient with hepatitis C as the associated risk factor [PDF]

Current Medical Mycology
Background and Purpose: In the context of HIV/AIDS, cryptococcosis emerges as one of the most common opportunistic infections, with a predilection for affecting individuals with compromised immune function.Case Report: This study aimed to present a ...
Pallavi Dhawan, Varsha Gupta, Monica Gupta, Parakriti Gupta, Nidhi Singla   +4 more
doaj   +1 more source

Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients [PDF]

, 2013
Genetic variation in the IL28B gene has been strongly associated with treatment outcomes, spontaneous clearance and progression of the hepatitis C virus infection (HCV).
Alaoui, Rihmou, Diepolder H., Salwa Nadir, Helmut Diepolder, Thursz, Mark, Sayeh Ezzikouri (143566), Khakoo Salim I., Mark Thursz, Soumaya Benjelloun (143569), Alaoui R., Alaoui Rhimou, Khakoo, Salim I., Mark Thursz (276871), Helmut Diepolder (276870), Nadir S., Ezzikouri Sayeh, Rebbani K., Nadir Salwa, Fakhir Fatima-Zohra, Fakhir F.-Z., Benjelloun, Soumaya, Benjelloun S., Fatima-Zohra Fakhir, Salim I Khakoo, Diepolder, Helmut, Thursz Mark, Nadir, Salwa, Benjelloun Soumaya, Brahim Ikram, Rhimou Alaoui, Rhimou Alaoui (276865), Brahim I., Diepolder, Helmut M., Sayeh Ezzikouri, Rebbani Khadija, Ikram Brahim, Alaoui, Rhimou, Rebbani, Khadija, Fatima-Zohra Fakhir (276868), Soumaya Benjelloun, Khadija Rebbani, Ikram Brahim (276867), Ezzikouri S., Salwa Nadir (276869), Khakoo S.I., Thursz M., Diepolder Helmut, Khadija Rebbani (276866), Salim I. Khakoo (201172), Fakhir, Fatima-Zohra, Ezzikouri, Sayeh, Brahim, Ikram   +51 more
core   +1 more source

OE-Abiodun/HIV-HCV-COINFECTION-SIM-CODE: HIV-HCV Co-infection

, 2022
MAPLE SIMULATION CODE FOR HIV-HCV MODEL.zip Full Changelog: https://github.com/OE-Abiodun/HIV-HCV-COINFECTION-SIM-CODE/commits/v3.0.
Oluwakemi Elizabeth Abiodun
core   +1 more source

Chicken Pulmonary MicroRNAs Targeting the PB2 (Segment 1) of Avian Influenza Virus

Animal Research and One Health, EarlyView.
The PB2 segment of H5N1 is essential for replication and host adaptation. We screened 200 miRNAs and identified five (gga‐miR‐17‐3p, gga‐miR‐29a‐5p, gga‐miR‐1718, gga‐miR‐16c‐5p, and gga‐miR‐1744‐5p) using thermodynamic stability of heteroduplex, seed sequence complementarity, conservation, and accessibility, offering insights into host antiviral ...
Akanksha Choudhary, Nidhishree N. S, Rakesh Kumar Pundir, Muhasin Asaf V. N, Anamika Mishra, Ashwin Ashok Raut, Megha Agarwal, Amod Kumar   +7 more
wiley   +1 more source

Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany [PDF]

, 2012
Objectives: This summary evaluates the outcomes of orthotopic liver transplantation (OLT) of HIV-positive patients in Germany. Methods: Retrospective chart analysis of HIV-positive patients, who had been liver-transplanted in Germany between July ...
T. Sauerbruch, J. Kittner, S. Manekeller, A. Paul, Anadol, Evrim, Beckebaum, Susanne, Rockstroh, Jürgen, T. Ganten, Paul, Andreas, Bickel, Markus, J. C. Kalff, Spengler, Ulrich, E. Anadol, M. Stoll, Zoufaly, Alexander, S. Beckebaum, Kittner, Jens Martin, M. Bickel, Hitzenbichler, Florian, Stoll, Matthias, Kalff, Jörg C., A. Zoufaly, Manekeller, Steffen, Ganten, Tom M., C. Berg, F. Hitzenbichler, J. K. Rockstroh, Radecke, Klaus, K. Radecke, Berg, C., U. Spengler, Sauerbruch, Tilman   +31 more
core   +1 more source

Driving continuous improvement of sustainability certification for industrial biobased systems through comprehensive sustainability requirements

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Existing monitoring frameworks for sustainability certification schemes and labels (CSLs) have largely prioritised environmental aspects, while the social and economic pillars of sustainability remain comparatively underdeveloped. Also, dedicated circularity requirements tailored to biobased systems are still largely lacking, despite being ...
Iris Vural Gursel, Heleen Ballemans, Heike Axmann, Lesly Garcia‐Chavez, Marta Rodriguez‐Illera, Laura Väyrynen   +5 more
wiley   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

HCV [PDF]

, 2019
???????????????????????? ?????????????????????? ???????????? ?? ???????????????????????????????????? ???????????????????????? ?????????????????? ???????????????? ?? ?? ????????, ?????????????? ?? ?????????????????????? ??????????????. ???????????????????? ?????????????????????? ???????????? ?????????????? ?? ???????????? ?????????????? ?????????????????
  +6 more sources

Non-invasive quantification of liver fibrosis regression following successful treatment of chronic hepatitis C with direct acting antivirals

Romanian Journal of Laboratory Medicine, 2017
Introduction. The past years have revolutionized the treatment of hepatitis C virus (HCV) infection, with high rates of sustained virologic response (SVR). Furthermore, liver fibrosis has recently been redefined as a dynamic, reversible process. Methods.
Nițescu Maria, Vâjâitu Cristina, Săndulescu Oana, Streinu-Cercel Adrian, Pițigoi Daniela, Preoțescu Liliana Lucia, Streinu-Cercel Anca   +6 more
doaj   +1 more source

Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. [PDF]

, 2011
In developed countries the majority of hepatitis C virus (HCV) infections occur in injecting drug users (IDUs) with prevalence in IDUs often high, but with wide geographical differences within countries.
Morongiu, A, V. D. HOPE, D. DE ANGELIS, Harris, R. J., Morongiu, A., DE Angelis, D, Hickman, Matthew, Ncube, F, R. J. HARRIS, Hope, V. D., Hope, VD, A. MORONGIU, de Angelis, D., Harris, RJ, Hickman, M, Ncube, F., M. HICKMAN, F. NCUBE   +17 more
core   +1 more source